Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glimepiride and metformin combination in type 2 diabetes mellitus
NCT01459809Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2012
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 14
01
Overview
A Phase 3 trial of glimepiride, liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Feb 2012; status: completed.
02
Drugs
glimepirideliquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01459809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01459809.